JPS5772920A - Carcinostatic agent containing blood plasma or blood serumal lipoprotein - Google Patents
Carcinostatic agent containing blood plasma or blood serumal lipoproteinInfo
- Publication number
- JPS5772920A JPS5772920A JP55149441A JP14944180A JPS5772920A JP S5772920 A JPS5772920 A JP S5772920A JP 55149441 A JP55149441 A JP 55149441A JP 14944180 A JP14944180 A JP 14944180A JP S5772920 A JPS5772920 A JP S5772920A
- Authority
- JP
- Japan
- Prior art keywords
- lipoprotein
- blood
- blood plasma
- serumal
- specific gravity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
PURPOSE: A carcinostatic agent, containing a blood plasma or blood serumal lipoprotein with almost no side effects.
CONSTITUTION: The concentration of a blood plasma or blood serumal lipoprotein is adjusted to an optimal value of 1/100W10 times according to the purpose to give a carcinostatic agent in the form of an injection, etc. A lipoprotein derived from a man, particularly a healthy man, is preferred, and the lipoprotein can be separated from the blood plasma or blood serum by the methods, e.g. the gel filtration, ultracentriguation, electroresist or precipitation. The respectve fractions of the separated lipoprotein contain chylomicron a very low specific gravity lipoprotein (VLDL), low specific gravity lipoprotein (LDL), high specific gravity lipoprotein (HLD), ultrahigh specific gravity lipoprotein (LHDL), and particularly LDL and HLD are preferred. Various lipoprotein pharmaceuticals in a dose corresponding to the lipoprotein contained in 1W200Ml blood plasma or blood serum of a healthy man are preferably administered parenterally or orally one W several times a day for an adult.
COPYRIGHT: (C)1982,JPO&Japio
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP55149441A JPS5772920A (en) | 1980-10-27 | 1980-10-27 | Carcinostatic agent containing blood plasma or blood serumal lipoprotein |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP55149441A JPS5772920A (en) | 1980-10-27 | 1980-10-27 | Carcinostatic agent containing blood plasma or blood serumal lipoprotein |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5772920A true JPS5772920A (en) | 1982-05-07 |
JPH0140810B2 JPH0140810B2 (en) | 1989-08-31 |
Family
ID=15475178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP55149441A Granted JPS5772920A (en) | 1980-10-27 | 1980-10-27 | Carcinostatic agent containing blood plasma or blood serumal lipoprotein |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5772920A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0366277A2 (en) * | 1988-09-29 | 1990-05-02 | Patralan Limited | Pharmaceutical formulations |
-
1980
- 1980-10-27 JP JP55149441A patent/JPS5772920A/en active Granted
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0366277A2 (en) * | 1988-09-29 | 1990-05-02 | Patralan Limited | Pharmaceutical formulations |
US5656289A (en) * | 1988-09-29 | 1997-08-12 | Patralan Limited | Pharmaceutical formulations that have a biologically active hydrophilic phase and a chylomicra-containing hydrophobic phase |
Also Published As
Publication number | Publication date |
---|---|
JPH0140810B2 (en) | 1989-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Makowske et al. | Contrasts in transport systems for anionic amino acids in hepatocytes and a hepatoma cell line HTC. | |
ES8500060A1 (en) | Stabilized insulin preparations | |
ES8403025A1 (en) | Stabilized insulin preparations and a process for preparation thereof | |
GB2124079B (en) | Process for prolonging retention of emulsion particles in the bloodstream | |
ES2177796T3 (en) | EXTRACTION BY SOLVENT OF POLYHYDROXIALCANOATS FROM BIOMASSFACILITATED BY THE USE OF A MARGINAL NON-SOLVENT FOR PHA. | |
EP0319557A4 (en) | Reconstituted hdl particles and uses thereof | |
MA22915A1 (en) | METHODS OF TREATING OSTEOPOROSIS FOR THE USE OF LOW DOSES OF PHOSPHONATES. | |
FR2437834A1 (en) | L-serine or glycine for treatment of cerebral deficiencies - such as mongolism and general mental debility, etc. | |
HUT63863A (en) | Complex comprising anticoagulant ix factor | |
ES485640A1 (en) | Process for the preparation of cold-insoluble globulin and medicament containing it. | |
JPS5228947A (en) | Oral remedy for hyperlipemia | |
JPS5772920A (en) | Carcinostatic agent containing blood plasma or blood serumal lipoprotein | |
Burge et al. | Inhibition of the alternative pathway of complement by gold sodium thiomalate in vitro | |
GB2050833A (en) | Pharmaceutical compositions and process for the preparation thereof | |
Steele et al. | Lipoprotein interaction with artery wall derived proteoglycan: comparisons between atherosclerosis-susceptible WC-2 and resistant Show Racer pigeons | |
EP0652755A1 (en) | Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine. | |
DeLisi et al. | P-chlorophenylalanine trials in schizophrenic patients. | |
IL101908A (en) | Process for extraction of antineoplastic substances from plants of the family pittosporaceae, extracts obtained thereby, and pharmaceutical preparations containing them | |
Cronholm et al. | Decrease in arachidonoyl-containing phosphatidylinositols in pancreas of rats fed an ethanol-containing diet | |
FR2570503B1 (en) | DEVICE FOR SEPARATING PLASMA FROM THE OTHER CONSTITUENTS OF A BLOOD LIQUID | |
ES8609363A1 (en) | Fractionation of blood plasma | |
ES2019017A6 (en) | Process for separation and concentration of apolipoproteins. | |
JPS56127307A (en) | Blood-coagulation factor 8 pharmaceutical for oral administration | |
NZ334634A (en) | Use of a protein extracted from mammalian liver for treating HIV | |
JPS51120054A (en) | Apparatus for separating solid matter and liquid from mud |